Corium International, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Corium International, Inc. | CORI - NASDAQ |
$10.00-$12.00 |
$8.00 |
$8.26 | 6.5 million | 4/3/2014 |
Jefferies, Leerink Partners |
Co-Manager(s): Needham & Co., FBR |
Health Care |
Filing(s): Filed 2014-03-03 Terms Added 2014-03-24
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Corium International, Inc., and our comprehensive analysis, click "Buy Market Research".
Corium International, Inc. Quote & Chart - Click for current quote -
CORI
About Corium International, Inc. (adapted from Corium International, Inc. prospectus):
They are a commercial stage biopharmaceitucal company focused on the development, manufacture and commercialization of specialty, pharmaceutical products that leverage our broad experience in transdermal and transmucosal delivery systems.
This description is adapted from Corium CORI prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as Corium CORI "CORI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved